Skip to content

PGL PHARMA

Active Private limited companyfounded 2021active for 5 yearsDeigné 90, 4920 AywailleKBO/BCE: BE 0764.558.948

Board

3 directors, since incorporation
Director (not named in the articles), permanent representative
appointed by deed of 05-03-2021 term without a fixed end
listed in the 2025 annual accounts, filed on 30-04-2026
Director (not named in the articles), permanent representative
appointed by deed of 05-03-2021 term without a fixed end
listed in the 2025 annual accounts, filed on 30-04-2026
Director (not named in the articles), permanent representative
appointed by deed of 05-03-2021 term without a fixed end
also on the board of 2 other companies
listed in the 2025 annual accounts, filed on 30-04-2026
Permanent representatives 3
Permanent representative, for
appointed by deed of 05-03-2021
Permanent representative, for
appointed by deed of 05-03-2021
Permanent representative, for
appointed by deed of 05-03-2021

Office holders in the KBO →

Mandates through the years

3 names, the dashed line is today

Director (not named in the articles)

Director (not named in the articles)

Director (not named in the articles)
Board
Mandates as a list
    • Director (not named in the articles), appointed by deed of 05-03-2021, still in office
    • Director (not named in the articles), appointed by deed of 05-03-2021, still in office
    • Director (not named in the articles), appointed by deed of 05-03-2021, still in office

Control

Shareholder
Equity €616,388
Profit €62,110 in 2025 (profit €73,635 in 2024)
Checked score
33.33% via subsidiaries
This company
PGL PHARMA
Equity €226,332
Profit €47,372 in 2025

and 2 other shareholders

Capital

Contribution
€45,000
Shares
90
Contribution per share
€500
Equity per share
€2,515 in 2025
Source
deed of 05-03-2021

Owners through the years

as the annual accounts name them
via 33.33%
via 33.33%
via 33.33% until 2024
Owners as a list
    • 2021 to 2025: via 33.33%
    • 2021 to 2025: via 33.33%
    • 2021 to 2024: via 33.33%

Source: lists of holdings in the owners' accounts

Articles of association

deed of 05-03-2021 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
Moitié cédant et moitié acquéreurs proportionnellement si plusieurs, nullité
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Fourth Friday of May at 20:30
Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
No statutory auditor

Shareholders

3 owners

Owners 3

  • Equity €616,388 Profit of €62,110 in 2025 (profit of €73,635 in 2024) Checked score
    Sourceaccounts 2025
    33.33%via subsidiaries
  • Equity €247,031 Profit of €38,904 in 2025 (profit of €37,445 in 2024) Checked score
    Sourceaccounts 2025
    33.33%via subsidiaries
  • Equity €326,236 Profit of €25,797 in 2025 (profit of €46,920 in 2024) Checked score
    Sourceaccounts 2025
    33.33%via subsidiaries

Capital transactions

Shareholders according to the deeds
At incorporation deed of 05-03-2021 ↗
  • 30 shares (33.3%) · €15,000
  • 30 shares (33.3%) · €15,000
  • 30 shares (33.3%) · €15,000
Capital over time
  1. 05-03-2021 Incorporation · €45,000 · 90 shares

Next steps